Last reviewed · How we verify
GSC-loaded autologous dendritic cells
GSC-loaded autologous dendritic cells is a Biologic drug developed by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta. It is currently in Phase 1 development.
At a glance
| Generic name | GSC-loaded autologous dendritic cells |
|---|---|
| Sponsor | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GSC-loaded autologous dendritic cells CI brief — competitive landscape report
- GSC-loaded autologous dendritic cells updates RSS · CI watch RSS
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta portfolio CI
Frequently asked questions about GSC-loaded autologous dendritic cells
What is GSC-loaded autologous dendritic cells?
GSC-loaded autologous dendritic cells is a Biologic drug developed by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta.
Who makes GSC-loaded autologous dendritic cells?
GSC-loaded autologous dendritic cells is developed by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (see full Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta pipeline at /company/fondazione-i-r-c-c-s-istituto-neurologico-carlo-besta).
What development phase is GSC-loaded autologous dendritic cells in?
GSC-loaded autologous dendritic cells is in Phase 1.